Mary T Szela Insider Trading
Get free email notifications about insider trading for Mary T Szela.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mary T Szela. Mary T Szela is a Senior Vice President in ABBOTT LABORATORIES ($ABT) and an Chief Executive Officer in QLT INC/BC ($QLTI) and a Director in ALIMERA SCIENCES INC ($ALIM) and an Chief Executive Officer in Aegerion Pharmaceuticals, Inc. ($AEGR) and a Director in Kura Oncology, Inc. ($KURA) and a Director in Receptos, Inc. ($RCPT) and a Director in Coherus BioSciences, Inc. ($CHRS) and a Director in Prometheus Biosciences, Inc. ($RXDX).
Address: 100 ABBOTT PARK ROAD ABBOTT PARK 60064-6400 IL
Companies in which Mary T Szela is an Insider
ABBOTT LABORATORIES
Trading Symbol: ABTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Senior Vice President
Holdings: 119,342 shares
Current Value: $5,118,578
Latest Transaction: Dec 16 2011
$ABT Market Capitalization: $62.37B
$ABT Previous Close: $42.89
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Aegerion Pharmaceuticals, Inc.
Trading Symbol: AEGRIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Chief Executive Officer
Holdings: 0 shares
Latest Transaction: Nov 30 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ALIMERA SCIENCES INC
Trading Symbol: ALIMIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 22 2020
$ALIM Market Capitalization: $75.24M
$ALIM Previous Close: $1.16
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Coherus BioSciences, Inc.
Trading Symbol: CHRSIndustry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mary T Szela: Director
Holdings: 14,997 shares
Current Value: $399,670
Latest Transaction: Jan 13 2021
$CHRS Market Capitalization: $1.03B
$CHRS Previous Close: $26.65
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Kura Oncology, Inc.
Trading Symbol: KURAIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 26 2020
$KURA Market Capitalization: $124.74M
$KURA Previous Close: $6.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVELION THERAPEUTICS INC.
Trading Symbol: NVLNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Chief Executive Officer
Holdings: 6,632 shares
Latest Transaction: May 11 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Prometheus Biosciences, Inc.
Trading Symbol: RXDXIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Director
Holdings: 0 shares
Latest Transaction: Mar 11 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Receptos, Inc.
Trading Symbol: RCPTIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mary T Szela: Director
Holdings: 0 shares
Latest Transaction: Aug 27 2015
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mary T Szela
Sentiment: All, ABT, AEGR, ALIM, CHRS, KURA, NVLN, RXDX, RCPT
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 11 2021 | RXDX | Prometheus Bioscie ... | Szela Mary T | Director | Option Exercise | A | 19.00 | 40,000 | 760,000 | 40,000 | |
Jan 13 2021 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | A | 17.58 | 20,000 | 351,600 | 20,000 | |
Jun 26 2020 | KURA | Kura Oncology, Inc ... | Szela Mary T | Director | Option Exercise | A | 17.97 | 23,000 | 413,310 | 23,000 | |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 12.37 | 20,000 | 247,400 | 0 | |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 10.05 | 20,000 | 201,000 | 0 | |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Option Exercise | M | 2.50 | 14,997 | 37,500 | 0 | |
Jun 24 2020 | CHRS | Coherus BioScience ... | Szela Mary T | Director | Sell | S | 17.58 | 54,997 | 966,759 | 0 | 55 K to 0 (-100.00 %) |